AHCO
AdaptHealth Corp. NASDAQ Listed May 31, 2018$9.65
+1.26%
vs $9.53
Mkt Cap $1.3B
52w Low $8.30
26.6% of range
52w High $13.38
50d MA $11.24
200d MA $10.20
P/E (TTM)
-18.6x
EV/EBITDA
5.8x
P/B
0.8x
Debt/Equity
1.2x
ROE
-4.7%
P/FCF
5.9x
RSI (14)
40.70
ATR (14)
$0.34
Beta
1.50
50d MA
$11.24
200d MA
$10.20
Avg Volume
1.3M
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
220 West Germantown Pike · Plymouth Meeting, PA 19462 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | BMO | 0.34 | 0.27 | -20.6% | 8.86 | -0.5% | +5.3% | +0.0% | -2.7% | +0.8% | +5.4% | — |
| Nov 4, 2025 | BMO | 0.24 | 0.22 | -8.3% | 10.67 | -0.2% | -3.1% | +0.0% | -7.1% | -1.1% | -1.1% | — |
| Aug 5, 2025 | BMO | 0.15 | 0.01 | -93.3% | 10.11 | -0.1% | -2.6% | +0.0% | -5.8% | -1.0% | +1.5% | — |
| May 6, 2025 | BMO | 0.01 | 0.01 | +0.0% | 8.85 | -0.6% | -6.9% | +0.0% | +1.7% | +2.3% | +6.3% | — |
| Feb 25, 2025 | BMO | 0.25 | 0.39 | +56.0% | 10.64 | +0.0% | +4.3% | +0.0% | -0.1% | +2.6% | -3.3% | — |
| Nov 5, 2024 | BMO | 0.17 | 0.15 | -11.8% | 9.18 | +3.4% | +10.9% | +0.0% | -3.4% | +2.6% | +3.6% | — |
| Aug 6, 2024 | BMO | 0.19 | 0.21 | +10.5% | 8.66 | +1.8% | +4.8% | +0.0% | +4.4% | -0.6% | -0.1% | — |
| May 7, 2024 | BMO | 0.06 | 0.02 | -66.7% | 9.76 | -1.0% | -0.7% | +0.0% | -5.2% | +5.2% | -1.8% | — |
| Feb 27, 2024 | BMO | 0.20 | 0.64 | +220.0% | 10.00 | +2.0% | +2.7% | +0.0% | -0.4% | +2.8% | +0.6% | — |
| Nov 7, 2023 | BMO | 0.19 | 0.19 | +0.0% | 7.69 | -6.0% | -15.5% | +0.0% | +4.8% | +1.0% | +10.2% | — |
| Aug 8, 2023 | BMO | 0.11 | 0.16 | +45.5% | 14.68 | +2.0% | +0.6% | +0.0% | -5.2% | -0.9% | -0.3% | — |
| May 9, 2023 | BMO | 0.08 | 0.01 | -87.5% | 11.30 | -2.0% | -2.1% | +0.0% | -8.8% | +5.1% | +4.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 | Truist | Maintains | Buy → Buy | — | $12.17 | $12.26 | +0.7% | +1.2% | +3.7% | -0.9% | -0.6% | +0.6% |
| Feb 26 | Leerink Partners | Maintains | Outperform → Outperform | — | $9.33 | $9.35 | +0.2% | -2.7% | +0.8% | +5.4% | -2.5% | +2.9% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.34 | $10.27 | -0.7% | -7.1% | -1.1% | -1.1% | +1.5% | -2.3% |
| May 12 | Truist | Maintains | Buy → Buy | — | $8.57 | $9.00 | +5.0% | +6.3% | -0.9% | -1.4% | +1.6% | -0.2% |
| May 8 | RBC Capital | Maintains | Outperform → Outperform | — | $8.24 | $8.28 | +0.5% | +1.7% | +2.3% | +6.3% | -0.9% | -1.4% |
| Feb 27 | Baird | Maintains | Outperform → Outperform | — | $11.10 | $11.22 | +1.1% | -0.1% | +2.6% | -3.3% | -6.0% | +1.0% |
| Feb 26 | Truist | Maintains | Buy → Buy | — | $10.64 | $10.64 | +0.0% | +4.3% | -0.1% | +2.6% | -3.3% | -6.0% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $10.64 | $10.64 | +0.0% | +4.3% | -0.1% | +2.6% | -3.3% | -6.0% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.64 | $10.64 | +0.0% | +4.3% | -0.1% | +2.6% | -3.3% | -6.0% |
| Feb 13 | UBS | Maintains | Buy → Buy | — | $8.95 | $8.99 | +0.4% | -0.2% | -1.7% | -0.5% | +3.0% | -2.6% |
| Nov 19 | RBC Capital | Maintains | Outperform → Outperform | — | $9.57 | $9.33 | -2.5% | +1.8% | -0.2% | +1.7% | -0.3% | +2.6% |
| Nov 15 | Truist | Maintains | Buy → Buy | — | $10.04 | $10.08 | +0.4% | -4.0% | -0.7% | +1.8% | -0.2% | +1.7% |
| Nov 6 | UBS | Maintains | Buy → Buy | — | $9.18 | $9.49 | +3.4% | +10.9% | -3.4% | +2.6% | +3.6% | +2.3% |
| Nov 6 | Baird | Maintains | Outperform → Outperform | — | $9.18 | $9.49 | +3.4% | +10.9% | -3.4% | +2.6% | +3.6% | +2.3% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.18 | $9.49 | +3.4% | +10.9% | -3.4% | +2.6% | +3.6% | +2.3% |
| Aug 12 | RBC Capital | Maintains | Outperform → Outperform | — | $9.42 | $9.47 | +0.5% | -0.1% | +3.1% | +0.4% | +5.0% | +2.2% |
| May 15 | Truist | Maintains | Buy → Buy | — | $9.83 | $10.02 | +1.9% | +0.1% | +0.1% | +1.3% | -0.9% | -1.3% |
| Mar 4 | RBC Capital | Maintains | Outperform → Outperform | — | $10.52 | $10.66 | +1.3% | +0.6% | -2.0% | +1.1% | +4.6% | -1.0% |
| Feb 28 | Truist | Maintains | Buy → Buy | — | $10.00 | $10.20 | +2.0% | +2.7% | -0.4% | +2.8% | +0.6% | -2.0% |
| Feb 28 | UBS | Maintains | Buy → Buy | — | $10.00 | $10.20 | +2.0% | +2.7% | -0.4% | +2.8% | +0.6% | -2.0% |
| Jan 29 | UBS | Maintains | Buy → Buy | — | $7.09 | $7.02 | -1.0% | +3.8% | -1.4% | -0.6% | +1.4% | +2.0% |
| Nov 8 | Truist | Maintains | Buy → Buy | — | $7.69 | $7.23 | -6.0% | -15.5% | +4.8% | +1.0% | +10.2% | +11.5% |
| Nov 8 | RBC Capital | Maintains | Outperform → Outperform | — | $7.69 | $7.23 | -6.0% | -15.5% | +4.8% | +1.0% | +10.2% | +11.5% |
| Nov 8 | BofA Securities | Downgrade | Neutral → Underperform | — | $7.69 | $7.23 | -6.0% | -15.5% | +4.8% | +1.0% | +10.2% | +11.5% |
| Oct 11 | Truist | Maintains | Buy → Buy | — | $8.41 | $8.22 | -2.3% | -10.4% | -0.3% | -0.9% | -3.2% | +4.3% |
| Sep 22 | BofA Securities | Maintains | Neutral → Neutral | — | $8.66 | $8.61 | -0.6% | -0.7% | +2.3% | -0.6% | +0.3% | +0.7% |
| Jul 13 | Baird | Maintains | Outperform → Outperform | — | $12.74 | $13.03 | +2.3% | +0.5% | +4.3% | +0.9% | +7.2% | -0.8% |
| Jun 28 | Baird | Maintains | Outperform → Outperform | — | $11.28 | $11.27 | -0.1% | +2.9% | +3.1% | +1.7% | -1.6% | -0.3% |
| Jun 27 | Baird | Maintains | Outperform → Outperform | — | $9.43 | $9.41 | -0.2% | +19.6% | +2.9% | +3.1% | +1.7% | -1.6% |
| May 11 | RBC Capital | Maintains | Outperform → Outperform | — | $11.06 | $10.99 | -0.6% | -8.8% | +5.1% | +4.8% | -0.2% | +1.2% |
| May 10 | Baird | Maintains | Outperform → Outperform | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Stifel | Downgrade | Buy → Hold | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Truist | Maintains | Buy → Buy | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Deutsche Bank | Downgrade | Buy → Hold | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 9 | BofA Securities | Downgrade | Buy → Neutral | — | $12.07 | $10.86 | -10.0% | -6.4% | -2.1% | -8.8% | +5.1% | +4.8% |
| Apr 13 | Truist | Maintains | Buy → Buy | — | $12.08 | $12.14 | +0.5% | +0.7% | -1.7% | -1.6% | -0.9% | +2.1% |
| Mar 1 | Baird | Maintains | Outperform → Outperform | — | $15.99 | $15.95 | -0.3% | -5.4% | +2.4% | +3.2% | -6.6% | +0.8% |
| Nov 10 | SVB Leerink | Maintains | Outperform → Outperform | — | $20.72 | $21.79 | +5.2% | +9.1% | +1.0% | -3.9% | +0.0% | -2.0% |
| Sep 20 | Deutsche Bank | Maintains | Buy → Buy | — | $22.12 | $22.35 | +1.0% | -1.9% | -6.1% | -1.9% | -3.9% | +0.4% |
| Sep 19 | Truist | Maintains | Buy → Buy | — | $20.15 | $20.51 | +1.8% | +9.8% | -1.9% | -6.1% | -1.9% | -3.9% |
| Aug 10 | RBC Capital | Maintains | Outperform → Outperform | — | $22.24 | $21.84 | -1.8% | +5.3% | -1.0% | +1.9% | -1.8% | -5.1% |
| Aug 10 | SVB Leerink | Maintains | Outperform → Outperform | — | $22.24 | $21.84 | -1.8% | +5.3% | -1.0% | +1.9% | -1.8% | -5.1% |
| Jul 14 | Truist | Maintains | Buy → Buy | — | $19.44 | $19.56 | +0.6% | +0.9% | +2.7% | +0.6% | +0.0% | +2.8% |
| Mar 8 | RBC Capital | Maintains | Outperform → Outperform | — | $15.54 | $15.44 | -0.6% | +7.4% | +0.0% | -2.6% | -4.6% | -1.1% |
| Mar 2 | SVB Leerink | Maintains | Outperform → Outperform | — | $15.92 | $15.94 | +0.1% | -4.0% | -1.8% | +0.7% | +2.9% | +7.4% |
| Feb 18 | SVB Leerink | Maintains | Outperform → Outperform | — | $17.43 | $17.50 | +0.4% | -3.8% | -6.2% | -1.1% | -2.4% | +6.6% |
| Nov 5 | SVB Leerink | Maintains | Outperform → Outperform | — | $25.85 | $26.17 | +1.2% | -3.5% | +2.8% | -4.6% | +3.1% | -0.9% |
| Sep 27 | SVB Leerink | Maintains | Outperform → Outperform | — | $23.00 | $23.23 | +1.0% | +3.3% | -1.6% | -0.6% | +0.2% | +1.2% |
| Jul 14 | Baird | Upgrade | Neutral → Outperform | — | $26.27 | $26.83 | +2.1% | -2.6% | +0.7% | -1.1% | -5.9% | -4.6% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Schuster III Russell E.Off | Chief Commercial Officer | Sell | 11,275 | $10.06 | $113K | 136,538 | +0.10% | +1.22% |
8-K · 5.02
!!! Very High
AdaptHealth Corp. -- 8-K 5.02: Executive Change
AdaptHealth Corp. appointed Daniel McFadden as Chief Operating Officer while director Toby Scott Barnhart resigned, signaling potential management restructuring that investors should monitor for strategic implications.
May 5
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
BAC and AHCO's new debt agreement likely increases borrowing capacity and financial flexibility, which could support growth initiatives or improve balance sheet strength, benefiting shareholders if capital deployment is effective.
Apr 13
8-K
AdaptHealth Corp. -- 8-K Filing
AdaptHealth reported fourth-quarter and full-year 2025 financial results as a leading home healthcare provider offering medical equipment, supplies, and related services.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Deerfield Management Company, L.p. | 11,477,730 | $137M | — | Mar 2026 |
| 2 | Reinhart Partners, Llc. | 10,081,983 | $120M | Added | Mar 2026 |
| 3 | Skyknight Capital, L.p. | 8,580,443 | $102M | — | Mar 2026 |
| 4 | Fmr Llc | 8,054,691 | $96M | Added | Mar 2026 |
| 5 | Vanguard Portfolio Management Llc | 6,105,860 | $73M | New | Mar 2026 |
| 6 | Vanguard Capital Management Llc | 4,498,018 | $54M | New | Mar 2026 |
| 7 | Segall Bryant & Hamill, Llc | 3,478,592 | $41M | New | Mar 2026 |
| 8 | Principal Financial Group Inc | 2,225,959 | $22M | — | Dec 2025 |
| 9 | Morgan Stanley | 2,058,648 | $21M | Added | Dec 2025 |
| 10 | Invesco Ltd. | 1,639,882 | $20M | Reduced | Mar 2026 |
| 11 | Royal Bank Of Canada | 1,467,992 | $17M | Reduced | Mar 2026 |
| 12 | Northern Trust Corp | 1,230,619 | $15M | Added | Mar 2026 |
| 13 | Aqr Capital Management Llc | 966,419 | $12M | Added | Mar 2026 |
| 14 | Arrowstreet Capital, Limited Partnership | 847,085 | $10M | Added | Mar 2026 |
| 15 | Neuberger Berman Group Llc | 829,951 | $10M | Added | Mar 2026 |
| 16 | Bank Of New York Mellon Corp | 681,691 | $8M | Reduced | Mar 2026 |
| 17 | Millennium Management | 661,220 | $8M | Added | Mar 2026 |
| 18 | Ubs Group Ag | 559,415 | $7M | Added | Mar 2026 |
| 19 | Sei Investments Co | 541,331 | $6M | Added | Mar 2026 |
| 20 | Peregrine Capital Management Llc | 467,704 | $6M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.30B
Enterprise Value
$2.91B
P/E (TTM)
-18.56x
Forward P/E
9.66x
PEG Ratio
0.10x
P/B
0.85x
P/S
0.40x
P/FCF
5.94x
EV/EBITDA
5.79x
Shares Out
135.1M
Financials (TTM)
Revenue
$3.24B
Net Income
-$70.8M
EBITDA
$503.6M
Free Cash Flow
$219.4M
Op Cash Flow
$601.8M
EPS Basic
$-0.52
EPS Diluted
$-0.52
EPS Forward
$1.00
Gross Margin
17.5%
Op Margin
5.7%
Net Margin
-2.2%
Balance Sheet
Total Assets
$4.32B
Total Liab.
$2.79B
Total Equity
$1.53B
Cash
$106.1M
LT Debt
$1.72B
Book Value/Sh
$11.29
Debt/Equity
1.25x
Current Ratio
1.02
Quick Ratio
0.81
Returns & Growth
ROE
-4.7%
ROA
-1.6%
ROIC
5.1%
Rev Growth YoY
-0.5%
EPS Growth YoY
-183.9%
Price Returns
2W
-5.7%
1M
-22.7%
3M
+10.7%
6M
+4.9%
12M
+12.8%
Technicals
52W High
$13.38
52W Low
$8.30
50d MA
$11.24
200d MA
$10.20
RSI (14)
40.70
ATR (14)
$0.34
Beta
1.50
Avg Volume
1.3M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$12.00
High
$13.00
Low
$11.00
Median
$12.00
Data updated apr 24, 2026 4:42pm
· Source: financialmodelingprep.com